Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Oehler

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Pediatric Blood & Cancer|August 12, 2016
miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology GroupRanjani Ramamurthy, Maya Hughes, Valerie Morris, et al.
Leukemia|August 20, 2024
Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trialCarlo Gambacorti-Passerini, Tim H Brümmendorf, Elisabetta Abruzzese, et al.
Nature Communications|January 5, 2018
A machine learning approach to integrate big data for precision medicine in acute myeloid leukemiaSu-In Lee, Safiye Celik, Benjamin A Logsdon, et al.
JAMA Oncology|May 9, 2024
Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation TrialNoam E Kopmar, Kim Quach, Ted A Gooley, et al.
The Lancet. Haematology|December 22, 2015
Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics studyGiovanni Martinelli, Vivian G Oehler, Cristina Papayannidis, et al.
Nature Genetics|February 4, 2014
Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemiaBryan Zimdahl, Takahiro Ito, Allen Blevins, et al.
Blood|July 24, 2009
The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cellsVivian G Oehler, Katherine A Guthrie, Carrie L Cummings, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemiaVivian G Oehler, Jerald P Radich, Barry Storer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2018
Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDSMichael R Savona, Daniel A Pollyea, Wendy Stock, et al.
Cancer Cell|December 3, 2016
CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous LeukemiaJeevisha Bajaj, Takaaki Konuma, Nikki K Lytle, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Pediatric Blood & Cancer|August 12, 2016
miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology GroupRanjani Ramamurthy, Maya Hughes, Valerie Morris, et al.
Leukemia|August 20, 2024
Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trialCarlo Gambacorti-Passerini, Tim H Brümmendorf, Elisabetta Abruzzese, et al.
Nature Communications|January 5, 2018
A machine learning approach to integrate big data for precision medicine in acute myeloid leukemiaSu-In Lee, Safiye Celik, Benjamin A Logsdon, et al.
JAMA Oncology|May 9, 2024
Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation TrialNoam E Kopmar, Kim Quach, Ted A Gooley, et al.
The Lancet. Haematology|December 22, 2015
Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics studyGiovanni Martinelli, Vivian G Oehler, Cristina Papayannidis, et al.
Nature Genetics|February 4, 2014
Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemiaBryan Zimdahl, Takahiro Ito, Allen Blevins, et al.
Blood|July 24, 2009
The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cellsVivian G Oehler, Katherine A Guthrie, Carrie L Cummings, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemiaVivian G Oehler, Jerald P Radich, Barry Storer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2018
Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDSMichael R Savona, Daniel A Pollyea, Wendy Stock, et al.
Cancer Cell|December 3, 2016
CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous LeukemiaJeevisha Bajaj, Takaaki Konuma, Nikki K Lytle, et al.
Pageof 11